Location, location, location! Bristol-Myers acquires Zymogenetics

Seattle-based companies continue their streak of headlines. Following Dendreon, Alimera and soon-to-be Seattle Genetics, Zymogenetics made its own splash this week with its acquisition by Bristol-Myers Squibb. BMS did the deal for Zymo’s hepatitis C biologic treatment that has been the focus of a collaboration between the two companies.

Hep C is predicted to a grow into a multi-billion dollar market, and Vertex, J&J and Merck are already in the race. With ZymoGenetics, BMS becomes an immediate player in this growing market. On a lighter note, they also now control one of the more storied and attractive landmarks in the life sciences industry. Zymo’s corporate offices are on the shores of Lake Union in Seattle in a distinctive converted factory. Anyone who’s driven by has had their attention drawn by the enormous stacks protruding from the renovated historic steam plant. Without question, the office building is one of the more recognizable across the entire industry. Of course, neither company is speculating on the fate of Zymo’s offices or its employees until the deal closes.

So our question: Is Zymogenetics building the most unique for any life sciences company?   If not, submit your nomination.

Advertisement